Article

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series

University of Eastern Piedmont, Novara, Italy.
BJU International (Impact Factor: 3.13). 11/2011; 110(1):76-83. DOI: 10.1111/j.1464-410X.2011.10690.x
Source: PubMed

ABSTRACT OBJECTIVES To investigate cancer-related outcomes of chromophobe renal cell carcinoma (ChRCC) in a large multicentre dataset. To determine prognostic factors for recurrence-free survival (RFS) and cancer-specific survival (CSS) for this RCC histological type. PATIENTS AND METHODS In all, 291 patients with ChRCC were identified from a multi-institutional retrospective database including 5463 patients who were surgically treated for RCC at 16 Italian academic centres between 1995 and 2007. Univariable and multivariable Cox regression models were used to identify prognostic factors predictive of RFS and CSS after surgery for ChRCC. RESULTS At a median follow-up of 44 months, 25 patients (8.6%) had disease recurrence and 18 patients (6.2%) died from disease. The 5-year RFS and CSS rates were 89.3% and 93%, respectively. Gender (P = 0.014), clinical T stage (P = 0.017), pathological T stage (P = 0.003), and sarcomatoid differentiation (P = 0.032) were independent predictors of RFS at multivariable analysis. For CSS, there was an independent prognostic role for gender (P = 0.032) and stage (P = 0.019) among the clinical variables and for T stage (P = 0.016), N/M stage (P = 0.023), and sarcomatoid differentiation (P = 0.015) among the pathological variables. CONCLUSIONS Patients with ChRCC have a low risk of tumour progression, metastasis, and cancer-specific death. Patient gender, clinical and pathological tumour stage, and sarcomatoid differentiation are significant predictors of RFS and CSS for ChRCC.

Full-text

Available from: Alchiede Simonato, Jun 15, 2015
1 Follower
 · 
276 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: To analyze distinct clinico-pathological features and prognosis of patients with renal cell carcinoma aged =40 years in comparison to a reference group of patients aged 60-70 years. Overall 2.572 patients retrieved from a multi-center international database comprising of 6.234 patients with surgically treated renal cell carcinoma were included in this retrospective study. Clinical and histopathological features of 297 patients aged =40 years (4.8%) were analyzed in comparison with 2275 patients (36.5%) aged 60-70 years, who represented the reference group. The median follow-up was 59 months. The impact of young age and further parameters on disease-specific mortality and all-cause mortality was evaluated by multivariable Cox proportional-hazards regression analyses. Young patients underwent more frequently nephron-sparing surgery (27% vs. 20%; p=0.008) and regional lymph node dissection in comparison to older patients (38% vs. 32%; p=0.025). Organ-confined tumor stages (81% vs. 70%; p<0.001), smaller tumor diameters (4.5 cm vs. 4.7 cm; p=0.014), and chromophobe subtype (10% vs. 4%; p<0.001) were significantly more frequent in young patients. On multivariable analysis, older patients had a higher disease-specific (HR 2.21; p<0.001) and all-cause mortality (HR 3.05; p<0.001). The c-indices for the Cox models were 0.87 and 0.78, respectively. However, integration of the variable age group did not significantly gain predictive accuracy of the disease-specific and all-cause-mortality models. Young renal cell carcinoma patients (=40 years) display significantly different frequencies of clinical and histopathological features and show a significantly lower all-cause and disease-specific mortality compared to patients at the age between 60-70 years.
    The Journal of urology 08/2013; 191(2). DOI:10.1016/j.juro.2013.08.021 · 3.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Standard treatment of renal neoplasms remains surgical resection, and nephrectomy for localised renal cell carcinoma (RCC) still has the best chance of cure with excellent long-term results. For smaller renal masses, especially stage T1a tumours less than 4 cm, nephron-sparing surgery is often employed. However, small incidentally detected renal masses pose an important diagnostic dilemma as a proportion of them may be benign and could be managed conservatively. Renal oncocytoma is one such lesion that may pose little risk to a patient if managed with routine surveillance rather than surgery. Additionally, lower-risk RCC, such as small chromophobe RCC, may be managed in a similar way, although with more caution than the renal oncocytomas (RO). The ability to differentiate ROs from chromophobe RCCs, and from other RCCs with a greater chance of metastasis, would guide the physician and patient towards the most appropriate management, whether nephron-sparing surgical resection or conservative surveillance. Consistent accurate diagnosis of ROs is likely to remain elusive until modern molecular biomarkers are identified and applied routinely. This review focuses on the differentiation of renal oncocytomas and chromophobe RCCs. It summarises the history, epidemiology and clinical presentation of the renal neoplasms, explains the diagnostic dilemma, and describes the value, or not, of current molecular markers that are in development to assist in diagnosis of the renal neoplasms.
    Journal of clinical pathology 10/2013; 67(2). DOI:10.1136/jclinpath-2013-201895 · 2.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The simultaneous occurrence of different histological types of adjacent neoplasms in the same organ is called a collision tumour, and rarely occurs in the kidney. A 63-year-old female presented to the urology department with a 1-month history of a painless hematuria. The computed tomography scans of the abdomen revealed 2 heterogeneous incidental right renal masses. The patient underwent radical nephrectomy including lymphadenectomy without adjuvant therapy. Histopathological examination showed a type 2 renal collision tumour of the papillary renal cell carcinoma with eosinophilic cytoplasm and pseudostratified nuclei on papillary cores, and chromophobe renal cell carcinoma characterized by large polygonal cells with transparent reticulated cytoplasm and prominent cell membranes, which exhibited sarcomatoid transformation in the local area. Routine follow-up demonstrated no local or distant metastasis signs of recurrence at 20 months.
    07/2014; 8(7-8):E536-9. DOI:10.5489/cuaj.1811